AzTrials
AzTrials

Critical IllnessPHOENIXNCT06159868

Physiotherapy and Optimised Nutrition in Survivors of Critical Illness

A study testing Structured physiotherapy and rehabilitation in people with Critical Illness, run by University Hospitals Coventry and Warwickshire NHS Trust at 2 sites in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this randomised controlled feasibility study is to assess the feasibility and acceptability of individualised physiotherapy and optimised nutrition, delivered on the ward following discharge from intensive care to increase days alive and out of hospital, as well as the proposed methodology to optimise… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Critical Illness
What is being tested?
Structured physiotherapy and rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
2 sitesUnited Kingdom
Study dates
1 May 2024to 8 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults (≥ 18 years) that received ≥ 4 days advanced respiratory support (defined as invasive or non-invasive ventilation) on ICU,
  • Alive at ICU discharge
  • On-going physiotherapy and dietetic rehabilitation needs identified by the PICUPS tool (Defined as patients who are unable to transfer from bed to chair independently AND not able to meet nutritional requirements independently).

Who cannot join

  • Death expected within the next 72 hours,
  • Poor pre-ICU admission mobility (inability to walk > 10 metres with or without an aid)
  • mobilisation contraindicated (e.g., spinal injury),
  • Contraindication to or inability to tolerate enteral nutrition,
  • Significant brain injury and not recovered to a GCS of ≥ 14 by ICU discharge.

Trial locations and contacts

2 sites in 1 country.

United Kingdom2 sites
  • University Hospitals Coventry & Warwickshire

    Coventry, Midlands, CV2 2DX

  • Oxford University Hospitals Foundation Trust

    Oxford

Other trials in United Kingdom

About this study

Official title: Physiotherapy and Optimised Enteral Nutrition In the Post-acute Phase of Critical Illness (PHOENIX): A Randomised Controlled Feasibility Trial

The goal of this randomised controlled feasibility study is to assess the feasibility and acceptability of individualised physiotherapy and optimised nutrition, delivered on the ward following discharge from intensive care to increase days alive and out of hospital, as well as the proposed methodology to optimise design and delivery for a definitive evaluation trial. Specific objectives are:

  1. To assess acceptability of the intervention to users and providers. ii. To assess feasibility of recruitment procedures for a future trial. iii. To estimate recruitment, retention and measure completion rates for a future trial.

Participants will receive a combination of structured, individualised physiotherapy and optimised nutrition, beginning immediately following recruitment and continuing for up to 14days or hospital discharge, whichever is sooner. As a feasibility trial the primary outcomes to be assessed are around study feasibility. The investigators will also compare clinical outcomes for the intervention participants in comparison to those receiving standard care to see if the intervention increases the number of days alive and out of hospital within 30 days of recruitment.

Read the detailed description

Research question Is it feasible and acceptable to undertake a randomised controlled trial evaluating the clinical and cost-effectiveness of an individualised physiotherapy and nutrition support intervention, delivered on the ward following ICU discharge, in adult survivors of critical illness?

Background Each year in the UK, 140,000 patients are discharged from intensive care units (ICU) to general hospital wards, almost all with complex rehabilitation needs. Eighty-four percent of patients still require nutritional support and 98% are not physically independent. Despite this, many are discharged from ICU without a nutrition plan and failure to recognise malnutrition is common. Consequently, malnutrition persists in the ward environment, leading to poor outcomes in itself, and additionally acts as a barrier to successful physical rehabilitation. This transition from intensive care to the ward represents a key stage in the recovery journey, and a window for optimising physical independence prior to hospital discharge, decreasing the need for support in the community. However, uncertainty as to how best to provide ongoing rehabilitation combining adequate nutrition and exercise on the general ward has driven widespread variation in practice.

The investigators have previously shown the benefits of delivering a structured rehabilitation strategy in the ICU. However, the ward environment poses different challenges to the development of an integrated rehabilitation pathway. There is a need to evaluate the clinical and cost-effectiveness of structured rehabilitation strategies when delivered outside the ICU.

Aims To evaluate the feasibility and acceptability of conducting a randomised controlled trial evaluating the clinical and cost-effectiveness of structured, individualised physiotherapy and nutritional support in ward-based patients following ICU discharge.

Objectives:

  1. To assess acceptability of the intervention to users and providers ii. To assess feasibility of recruitment procedures for a future trial iii. To estimate recruitment, retention and measure completion rates

Methods PHOENIX is a two-centre, allocation-concealed, open-label, parallel group, randomised controlled feasibility trial with integrated qualitative evaluation of acceptability.

The investigators will recruit sixty adult survivors from intensive care units at two university hospitals, with ongoing physiotherapy and nutritional needs at ICU discharge. Participants will be randomised on a 1:1 basis to receive the structured rehabilitation intervention or standard care. The intervention comprises enhanced physiotherapy, delivered by a specialist critical care team, in combination with optimised nutrition guided by indirect calorimetry.

Primary feasibility outcomes are recruitment and retention rates, and intervention fidelity. Acceptability will be evaluated through semi structured interviews of participants and staff.

Being tested
Structured physiotherapy and rehabilitation, Standard care
Keywords
physiotherapy, nutrition, rehabilitation, intensive care, exercise
Medical subject headings
Critical Illness, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Structured physiotherapy and rehabilitationOther

    Comprehensive baseline assessment of function and nutrition using indirect calorimetry to identify nutritional requirements, to create and individualised plan for followed by daily targeted mobility retraining, exercise and nutrition.

  • Standard careOther

    Standard ward based care provided by usual care teams

Study groups in NCT06159868
Study groupRoleWhat they receive
InterventionExperimentalStructured and individualised physiotherapy in combination with optimised nutrition delivered by s specialist critical care rehabilitation team
Receives: Other: Structured physiotherapy and rehabilitation
ControlActive comparatorStandard ward based care
Receives: Other: Standard care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recruitment rate

    Proportion of patients agreeing to take part out of all those invited (recruitment rate)

    Measured: At recruitment within the 6 month screening window

  2. Retention rate

    Proportion of participants who complete the primary outcome (retention rate)

    Measured: from recruitment up to 30 days

  3. Intervention adherence

    Percentage of intervention sessions completed

    Measured: For 14 days following recruitment

Secondary outcomes (4)
  1. Days alive and out of hospital in 30 days

    To evaluate the number of days alive and out of hospital within the 30 days following recruitment

    Measured: 30 days following recruitment

  2. Physical Function

    Assessed using the 30 second sit to stand test

    Measured: At baseline, 14 days and 30 days

  3. Functional independence

    Assessed using the Barthel Index

    Measured: At baseline, 14 days and 30 days

  4. Health Related Quality of Life

    Assessed using the EQ5D-5L

    Measured: At 30 days following recruitment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Dec 2023
  2. Study start1 May 2024
  3. Primary completion8 Feb 2025
  4. Study completion8 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A mixed-methods, multicentre, randomised controlled feasibility study.
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06159868
Sponsor's protocol ID
DM633323
Acronym
PHOENIX
Status last verified
Nov 2025
First submitted
28 Nov 2023
Last updated
25 Nov 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • King E, Wyer N, Barghouthy D, Reynolds E, Richardson H, Negus-Fancey M, Gallie L, Puthucheary Z, Gustafson O, McWilliams D. Patient and clinician acceptability of an integrated physiotherapy and nutrition intervention after ICU discharge: a qualitative exploration of a pre-specified co-primary feasibility outcome of the PHOENIX trial. EClinicalMedicine. 2026 Jul 20;98:104085. doi: 10.1016/j.eclinm.2026.104085. eCollection 2026 Aug.

    PubMed 42495105
  • McWilliams D, Gustafson O, Wyer N, Couper K, Kimani PK, Kandiyali R, El-Banna A, Barghouthy D, Haylett R, King E, Richardson H, Negus-Fancey M, Gallie L, Matthews V, Puthucheary Z. Physiotherapy and optimised enteral nutrition in the post-acute phase of critical illness (PHOENIX): a randomised controlled feasibility trial. EClinicalMedicine. 2026 Jun 11;96:104000. doi: 10.1016/j.eclinm.2026.104000. eCollection 2026 Jun.

    PubMed 42326381
  • McWilliams D, Gustafson O, Wyer N, Couper K, Kimani P, Kandiyali R, Barghouthy D, Haylett R, Richardson H, Negus-Fancey M, King E, Gallie L, Puthucheary Z. Physiotherapy and Optimised Enteral Nutrition In the post-acute phase of critical illness (PHOENIX): protocol for a mixed methods feasibility randomised controlled trial. BMJ Open. 2025 Mar 27;15(3):e100803. doi: 10.1136/bmjopen-2025-100803.

    PubMed 40147993

Questions about this trial

What is this clinical trial studying?

A study testing Structured physiotherapy and rehabilitation in people with Critical Illness, run by University Hospitals Coventry and Warwickshire NHS Trust at 2 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Recruitment rate (time frame: At recruitment within the 6 month screening window). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06159868, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in